Attralus is a company that develops immunotherapies and an imaging diagnostic platform designed for multiple systemic amyloid disease treatment. The company specializes in the research and development of immunotherapies to clear amyloid fibrils in patients with systemic amyloid diseases, like a light chain(AL), transthyretin (ATTR), and LECT2 (ALECT2) amyloidosis.